Literature DB >> 2160616

(+)-sotalol causes significant occupation of beta-adrenoceptors at concentrations that prolong cardiac repolarization.

J Reid1, G Duker, O Almgren, V Nerme.   

Abstract

The racemate (+/-) and the two enantiomers of sotalol were studied with regard to the effects on cardiac repolarization. In addition, the affinity to cardiac beta-adrenoceptors was investigated for the enantiomers. The effect on left ventricular monophasic action potential duration was assessed in the isolated perfused guinea-pig heart and the beta-adrenoceptor affinity of the compounds was studied, using a radioligand binding technique, in cellular membranes prepared from the left ventricular free wall of the cat. Moreover, the beta-adrenoceptor blocking potency of (+)-sotalol was studied in isolated strips of guinea-pig papillary muscles. Both the racemate and the two enantiomers of sotalol caused a concentration-dependent prolongation of the ventricular monophasic action potential duration. The maximal effect and the concentration causing half maximal effect (EC50 = 13 mumol/l) were similar for the racemate and the enantiomers, indicating lack of stereoselectivity for this effect. The beta-adrenoceptor affinity (equilibrium dissociation constant) of (+)-sotalol was 11 mumol/l and 4 mumol/l as estimated by the binding technique and in the isolated muscle strips, respectively. The affinity for (-)-sotalol, estimated by binding, was 0.6 mumol/l. Thus, at concentrations of (+)-sotalol required for a significant prolongation of cardiac repolarization, this isomer may cause significant beta-blockade. In this study the enantiomeric purity was better than 98%, so that the degree of beta-blockade may be even more pronounced if the enantiomeric purity of the (+)-enantiomer is less than 98%.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2160616     DOI: 10.1007/BF00169733

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  30 in total

1.  Cardiovascular pharmacology of two new beta-adrenergic receptor antagonists.

Authors:  H C Stanton; T Kirchgessner; K Parmenter
Journal:  J Pharmacol Exp Ther       Date:  1965-08       Impact factor: 4.030

2.  Electrophysiologial and beta-receptor blocking effects of MJ 1999 on dog and rabbit cardiac tissue.

Authors:  H C Strauss; J T Bigger; B F Hoffman
Journal:  Circ Res       Date:  1970-06       Impact factor: 17.367

3.  Steric aspects of adrenergic drugs. 8. Optical isomers of beta adrenergic receptor antagonists.

Authors:  P N Patil
Journal:  J Pharmacol Exp Ther       Date:  1968-04       Impact factor: 4.030

4.  Pharmacological estimation of drug-receptor dissociation constants. Statistical evaluation. I. Agonists.

Authors:  R B Parker; D R Waud
Journal:  J Pharmacol Exp Ther       Date:  1971-04       Impact factor: 4.030

5.  Sotalol-induced delayed ventricular repolarization in man.

Authors:  N Edvardsson; I Hirsch; H Emanuelsson; J Pontén; S B Olsson
Journal:  Eur Heart J       Date:  1980-10       Impact factor: 29.983

6.  Recording of monophasic action potentials in the horizontally perfused guinea pig heart. An in vitro method to study drug-induced changes in cardiac electrophysiology.

Authors:  J J Reid; G Duker
Journal:  J Pharmacol Methods       Date:  1987-11

7.  Quantitative analysis of the selectivity of radioligands for subtypes of beta adrenergic receptors.

Authors:  K A Neve; P McGonigle; P B Molinoff
Journal:  J Pharmacol Exp Ther       Date:  1986-07       Impact factor: 4.030

8.  Some quantitative uses of drug antagonists.

Authors:  O ARUNLAKSHANA; H O SCHILD
Journal:  Br J Pharmacol Chemother       Date:  1959-03

9.  Electrophysiologic effects of d-sotalol in humans.

Authors:  J M McComb; B McGovern; J B McGowan; J N Ruskin; H Garan
Journal:  J Am Coll Cardiol       Date:  1987-07       Impact factor: 24.094

10.  Electrophysiologic effects of the levo- and dextrorotatory isomers of sotalol in isolated cardiac muscle and their in vivo pharmacokinetics.

Authors:  R Kato; N Ikeda; S M Yabek; R Kannan; B N Singh
Journal:  J Am Coll Cardiol       Date:  1986-01       Impact factor: 24.094

View more
  4 in total

1.  Influence of lorcainide on microsomal Na+, K(+)-ATPase in guinea-pig isolated heart preparations.

Authors:  A A Almotrefi; N Dzimiri
Journal:  Br J Pharmacol       Date:  1991-02       Impact factor: 8.739

2.  Variations in potassium concentration modify the inhibitory effect of lorcainide on myocardial Na(+)-K(+)-ATPase activity.

Authors:  A A Almotrefi; N Dzimiri
Journal:  Br J Pharmacol       Date:  1991-12       Impact factor: 8.739

Review 3.  Sotalol. An updated review of its pharmacological properties and therapeutic use in cardiac arrhythmias.

Authors:  A Fitton; E M Sorkin
Journal:  Drugs       Date:  1993-10       Impact factor: 9.546

4.  Molecular determinants of pro-arrhythmia proclivity of d- and l-sotalol via a multi-scale modeling pipeline.

Authors:  Kevin R DeMarco; Pei-Chi Yang; Vikrant Singh; Kazuharu Furutani; John R D Dawson; Mao-Tsuen Jeng; James C Fettinger; Slava Bekker; Van A Ngo; Sergei Y Noskov; Vladimir Yarov-Yarovoy; Jon T Sack; Heike Wulff; Colleen E Clancy; Igor Vorobyov
Journal:  J Mol Cell Cardiol       Date:  2021-05-29       Impact factor: 5.000

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.